DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Carfentanil is an investigational drug.
There have been 9 clinical trials for Carfentanil. The most recent clinical trial was a Phase 1 trial, which was initiated on April 1st 2012.
The most common disease conditions in clinical trials are Tobacco Use Disorder, Depression, and Substance-Related Disorders. The leading clinical trial sponsors are Johns Hopkins University, National Institute on Drug Abuse (NIDA), and Yale University.
There are four hundred and four US patents protecting this investigational drug and three international patents.
Recent Clinical Trials for Carfentanil
|Effects of Experimental Sleep Disturbances on Receptor Function of Study Drug||National Heart, Lung, and Blood Institute (NHLBI)||Phase 2|
|Effects of Experimental Sleep Disturbances on Receptor Function of Study Drug||Johns Hopkins University||Phase 2|
|Neurobiology of Treatment Responses in MDD||University of Utah||Phase 3|
Top disease conditions for Carfentanil
Top clinical trial sponsors for Carfentanil
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Carfentanil||Start Trial||Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse||Acura Pharmaceuticals, Inc. (Palatine, IL)||Start Trial|
|Carfentanil||Start Trial||Transdermal dosage form||Barr Laboratories, Inc. (Pomona, NY)||Start Trial|
|Carfentanil||Start Trial||Self-expanding devices and methods therefor||Intersect ENT, Inc. (Menlo Park, CA)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|